| Kathryn Kirmse, PHARMD | |
|
1008 17th Ave, Monroe, WI 53566-2005 | |
| (608) 325-2151 | |
| (608) 325-2153 |
| Full Name | Kathryn Kirmse |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1008 17th Ave, Monroe, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053957217 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 17877-40 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn Kirmse, PHARMD 7133 Field Flower Way, Madison, WI 53718-3431 Ph: (715) 641-0744 | Kathryn Kirmse, PHARMD 1008 17th Ave, Monroe, WI 53566-2005 Ph: (608) 325-2151 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that effective January 3, 2011, it will begin trading on the NASDAQ Global Select Market. The NASDAQ Global Select Market is the highest NASDAQ listing tier based on financial and liquidity criteria. Prior to the effectiveness of this change in the New Year, shares of Spectrum Pharmaceuticals will continue to be traded on the NASDAQ Global Market.
"The treatment of breast cancer when the patient is pregnant does not increase the risk of congenital anomalies", assures Dr. Guillermo López, director of the Department of Gynaecology and Obstetrics at the University Hospital of the University of Navarra.
Mesoblast Limited today announced that Mesoblast's proprietary allogeneic mesenchymal precursor cell heart failure product candidate MPC-150-IM for use in children with hypoplastic left heart syndrome was featured at the First Cardiac Regenerative Symposium for Congenital Heart Disease in Baltimore, Maryland on the weekend.
ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy™ platform to translate and deliver first-in-class peptide-based immune therapies to people living with autoimmune diseases, today announced that it has received an investment from the JDRF T1D Fund, a venture philanthropy fund exclusively devoted to finding and funding the best type 1 diabetes commercial opportunities.
› Verified 8 days ago
Nicole Lyn Carrico, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-1242 | |
Anna Metz, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-1242 | |
Michael Kuckes, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 W 8th St, Monroe, WI 53566 Phone: 608-325-3310 | |
Dr. Stephanie Marie Garvin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-2259 | |
Kent B Pieper, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-324-1242 | |
Ms. Barbara Marie Cappel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 515 22nd Ave, Monroe, WI 53566 Phone: 608-325-3111 Fax: 608-324-2439 |